The Bcl6 gene has been identified from the chromosomal translocation breakpoint in B cell lymphomas, and its products are expressed highly in germinal center (GC) B cells. To investigate the function of Bcl6 in lymphocytes, we have generated RAGl-deficient mice reconstituted with bone marrow cells from Bcl6-deficient mice (Bcl6-/-RM). Lymphogenesis in primary lymphoid tissues of Bcl6-/-RM is normal, and Bcl6-/-RM produced control levels of primary IgG1 antibodies specific to T cell-dependent antigens. However, GCs were not found in these mice. This defect was mainly due to the abnormalities of B cells. Therefore, Bcl6 is essential for the differentiation of GC B cells.
C
hromosomal translocations involving band 3q27 are often present in B cell lymphomas. The BCL6 gene was identified from the breakpoint of these translocations (1) (2) (3) . Rearrangements of the BCL6 gene were detected in up to 40% of diffuse large cell lymphomas and 10% of follicular lymphomas (4, 5) . These rearrangements cause deregulation of the BCL6 gene as a result of the juxtaposition of the BCL6 coding region to heterologous promoters (6) , and its deregulation may be responsible for lymphomagenesis. BCL6 is a 92-to 98-kD nuclear phosphoprotein (7, 8) that contains six Kriippel-type zinc finger motifs in COOH-terminal region (1) (2) (3) 9) , which have been shown to bind to specific DNA sequences in vitro (10, 11) , and the POZ/BTB domain (12, 13) in NH2-terminal region. Because a NH2-terminal half of the protein has been demonstrated to contain transrepressor domain(s) in vitro (14--16) , BCL6 can function as a sequence-specific transcriptional repressor.
The expression of BCL6 is ubiquitously detected in human tissues (17) . As this gene is well conserved between human and mouse (9) , the expression pattern has been extensively studied in mouse tissues. Bcl6 is continuously upregulated in keratinocytes and sperm at their terminal stages (18) . Bcl6 expression is also detected in mature lymphoid tissues and transiently upregulated in thymocytes and splenocytes when these cells were stimulated with chemical mediators (PMA plus ionomycin; 9). Furthermore, the expression is predominant in the germinal center (GC) 1 B cells of human tonsils, but is undetectable in plasma cells (7, 8) . However, the function of BCL6 in lymphocytes, especially in GC B cells, is unknown.
When mice are immunized with T cell-dependent antigens, antigen-reactive B cells in the spleen are activated by interaction with CD4 + helper T cells in periarteriolar lymphoid sheaths (PALS) (19, 20) . These activated B cells generate Ab-producing foci in PALS or migrate into follicles to form GCs that are identified by their binding capacity to peanut agglutinin (PNA). Nascent GC B cells undergo massive clonal expansion to form a dark zone occupied by surface Ig (slg)-negative centroblasts (21, 22) . Somatic hypermutations of the Ig gene occur in centroblasts (23) (24) (25) . These cells differentiate into slg-positive centrocytes at a light zone in GCs. Centrocytes with higher affinity to selfantigens or with lower affinity to immunized antigen undergo selective apoptosis (26) (27) (28) (29) (30) , and those with higher affinity to the antigen further differentiate into antibodyforming cells (AFCs) or m e m o r y B cells (31, 32) .
To investigate the function of Bcl6 in lymphocytes, we have generated Bcl6-deficient mice (Bcl6-/-). However, Bcl6 -/ -displayed growth retardation and mostly died with severe myocardial injury by 9 w k old CYoshida, T., manuscript in preparation). Therefore, we made tLAG1-deficient mice (ILAG1-/-) reconstituted with bone marrow (BM) cells from Bcl6 -/ -( B c l 6 -/ -R M ) . As t L A G l -d e f icient lymphocytes cannot develop into a mature form (33) , all mature lymphocytes developed in B c l 6 -/ -R M are derived from B M cells o f Bcl6 -/ -. Here, we analyzed the function of lymphocytes developed in B c l 6 -/ -I L M . Although mature lymphocytes were developed in spleen from B c l 6 -/ -R M , G C formation was impaired in the spleen. W e discuss the possible function of Bcl6 in G C B cells.
Materials and Methods
Animals. C57BL/6 mice were purchased from Japan SLC Co. Ltd. (Hamamatsu, Japan). Bcl6 -/ -(Yoshida, T., manuscript in preparation) and 1LAG1-/-(33) were described in detail previously.
mAbs and Flow Cytometry. mAbs used for cell surface staining were FITC-anti-B220 (tLA3-6B2; PharMingen, San Diego, CA), -anti-CD8 (Ly-2; PharMingen), biotinylated anti-IgM (II/41; PharMingen), PE-anti-CD4 (L3T4; PharMingen), a n d -a n t iCD3e (145-2Cll; PharMingen). For flow cytometric analysis, cells were stained with antibodies for 30 rain on ice. The cells were further incubated with a PE-streptavidin (PharMingen) for 15 min on ice. The stained cells were analyzed by FACSCalibur ~ (Becton Dickinson, San Jose, CA).
Generation of Bcl6-/-RM. tLAG1 -/ -(8-16 wk old) were sublethally irradiated (3.5 Gy) and injected with 2-5 X 106 BM cells from Bcl6 -/ -or Bcl6 +/+ littermates (3-5 wk old). The reconstitutions were confirmed 8-12 wk after transplantation by identifying CD3 + and B220 + mature lymphocytes in peripheral blood from Bcl6+/+RM and Bcl6-/-R.M with flow cytometry.
Immunization. DNP-OVA was prepared by coupling of OVA (Sigma Chemical Co., St. Louis, MO) with 2,4-dinitrophenylbenzensulfonic acid under alkaline condition (34) . N Pchicken ",/globulin (NP-CG) was made by reaction of succinirnide ester of 4-hydroxy-3-nitrophenyl acetyl (NP; Genosys Biotechnology, Inc., Woodlands, TX) and CG (Sigma Chemical Co.). Mice were immunized intraperitoneally with 100 Ixg of alumprecipitated DNP-OVA or NP-CG. Sera were collected from the mice 7 d (for IgM) and 14 d (for IgG1) after immunization. Amounts of DNP-specific Abs in the sera were measured by ELISA as described previously (34) .
Immunohistochemistry. A SmaI-XhoI fragment of murine Bd6 cDNA (mBcl6SX) was inserted into pGEX4T-2 vector (Pharmacia Biotech, Piscataway, NJ). The resulting glutathione-S-transferase (GST)-mBcl6SX fusion protein was used to immunize rabbits to raise anti-Bcl6 antibodies. The immune sera were precleared by passage through GST-Sepharose columns and affinity purified with antigen columns on which GST-mBcl6SX protein was coupled to activated CH Sepharose (Pharmacia Biotech).
Spleens were isolated from C57BL/6, Bcl6-/-RM, or Bcl6 +/+ RM after immunization, one third were used for flow cytometric 
Results

Bcl6 Is Strongly Detected in GC, but Not in PALS-associated Foci.
We have made polyclonal antibodies specific for mouse Bcl6 and immunohistologically analyzed the expression in GCs from spleens of immunized mice. The GC reaction in spleen reaches its maximum by days 10-12 and keeps the same high levels until day 21 after immunization (31, 36) . Therefore, expression of Bcl6 was examined in spleens of normal C57BL/6 mice immunized with T celldependent antigen, D N P -O V A , on day 14 after immunization (Fig. 1, A and B) . Bcl6 was detected strongly in nuclei of most of GC B cells and weakly in those of other lymphocytes in white pulps.
After activation by helper T cells in PALS, antigen-reactive B cells migrate into follicles to form GCs or generate Ab-producing foci in PALS. The PALS-associated foci can be identified by immunohistological staining of spleens from C57BL/6 mice immunized with an immunogenic conjugate of NP with anti-h light chain antibody (36) . The peak of the focus formation occurs on about day 10 after immunization (36) . Thus, Bcl6 expression in PALS-associated foci from the mice immunized with N P -C G was analyzed on day 7 after immunization. Although strong Bcl6 expression was detected in GCs, it was not detected in the PALS-associated foci (Fig. 1, C and D) . Anti-h light chain antibody used in this staining also distinguished centroblasts (slg-) from centrocytes (slg +) in GCs, in both of which Bcl6 expression was strongly upregulated.
Germinal Center Formation Is Impaired in Bd6-/-RM. Since Bcl6 -/ -mostly died at young age, the function of Bcl6 in lymphocyte development was investigated in R_AG1 -/ -reconstituted with BM cells from Bcl6 -/ -(Bcl6-/-RM). Flow cytometric analysis of BM cells and thymocytes from B c l 6 -/ -R M 3 mo after transplantation revealed no abnormality in early lymphocyte development (Fig. 2, A and B) . Percentages of B220 + B cells, CD4 +, or CD8 + T cells in spleens from the Bcl6-/-R.M were also comparable to those from Bcl6+/+ILM (Fig. 2, C and D) . Although Bcl6 expression can be detected in murine BM cells, thymocytes, and splenocytes (9), these data indicate that Bcl6 is not essential for lymphogenesis in primary lymphoid tissues.
We then analyzed the function of mature lymphocytes in B c l 6 -/ -R M by immunizing them with D N P -O V A . Titers of primary IgM and IgG1 anti-DNP Abs in sera from the mice on day 7 (IgM) and on day 14 (IgG1) after immunization were measured by ELISA. B c l 6 -/ -R M produced the primary IgM Abs and IgG1 Abs at levels comparable to those of Bcl6+/+RM (Fig. 3) . These results indicate that Bcl6 is not essential for differentiation of mature B cells into IgGl-producing plasma cells.
GC formation was histologically analyzed in spleens from mice immunized with D N P -O V A on day 14 after immunization. PNA-binding GC B cells were clearly iden-
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Fukuda et al. tried in all of the Bcl6+/+RM analyzed (n = 8, Fig. 4 , A and C). In contrast, none of the B c l 6 -/ -R M spleens (n = 8) showed PNA-binding B cells in follicles (Fig. 4 , B and D), although primary B cell follicles, marginal zones, and PALS were histologically identified (Fig. 4 F) . Because the great majority of Abs produced in the first 12 d after immunization are derived from PALS-associated foci (37) , the focus formation in PALS was histologically analyzed in spleens from B c l 6 -/ -R M immunized with N P -C G on day 7 after immunization with anti-k light chain antibody. PALS-associated foci and PNA-binding GCs could be detected in the Bcl6+/+RM (Fig. 5 A) . Although PNAbinding GCs were absent in the Bcl6-/-RM, PALS-associated foci could be identified (Fig. 5 B) . Therefore, Bcl6 is essential for GC formation in follicle but not for focus formation in PALS.
Bcl6 Is Required in B, but Not in T Cells for GC Formation.
Functions of T cells in GCs are essential for GC formation of B cells (38, 39) and BCL6 is detected in a small fraction of CD4 + T cells in GCs (7) . To determine whether defects in GC formation in B c l 6 -/ -R M are due to defects in B or T cells or both, splenic T and B cells were isolated from Bcl6-/-RNI and Bcl6+/+RM and then co-transferred into R A G 1 -/ -1 d before immunization with D N P -O V A . GC formation in the spleen was histologically analyzed 2 wk later. GC formation was detected in spleens from mice reconstituted with B cells from Bcl6+/+RM and T cells from Bcl6-/-R.M (Fig. 6 A) . In contrast, co-transfer of B cells from B c l 6 -/ -R M and T cells from Bcl6+/+RM did not restore GC formation (Fig. 6 B) , indicating that Bcl6 expression in B but not in T cells is essential for the G C formation.
Nascent G C Formation Is Absent in Spleen from
Bcl6 -/ -RM. GC first appears in splenic follicles by day 4 and begins to wane by day 21 after immunization (31) . It might be possible that GC formation occurs in B c l 6 -/ -R M shortly after immunization but cannot be maintained. To examine the possibility, the presence of PNA-binding GCs was examined in spleens from B c l 6 -/ -R M immunized with D N P -O V A at an early stage after immunization. Nascent P N Abinding GCs could be identified in the Bcl6÷/+RM spleen on day 3 after immunization ( Fig. 7 A) and Bcl6 was detected strongly in nuclei of these GC B cells (data not shown). However, the nascent GCs were not detected at all in the B c l 6 -/ -R M on day 3 (Fig. 7 B) and day 4 (data not shown) after immunization.
To exclude the possibility that nascent GC B cells from Bcl6-/-P,.M cannot obtain the PNA-binding capacity, the presence of blast cells in S phase in splenic follicles from the B c l 6 -/ -R M on day 3 after immunization was histologically analyzed using BrdU incorporation assay, because nascent G C B cells undergo massive clonal expansion in follicles (21, 22) . About half the numbers o f GC cells in spleen from the Bcl6+/+RM were positive for BrdU uptake 2 h after pulse (Fig. 7 A) . However, no BrdU-positive cells were detected in B cell follicles from the B c l 6 -/ -R M spleen (Fig. 7 B) , suggesting that antigen-reactive B cells activated by helper T cells in PALS cannot proliferate at all in splenic follicles.
W e then examined the capacity for proliferation o f ma-444 Bcl6 in Germinal Center Formation 
Discussion
Antigen-reactive B cells activated by helper T cells in PALS further differentiate into AFCs in PALS or GC B cells in follicles. We show here that Bcl6 is essential for differentiation of GC B cells (Fig. 4) . However, Bcl6 is not required for the focus formation in PALS by antigen-reactive B cells (Fig. 5) . This is also supported by the evidence that Bcl6 expression is not upregulated in PALS-associated loci (Fig. 1) . Because primary AFCs and GC B cells are thought to be derived from a common clonal origin (40) , Bcl6 may be an essential transcription factor for the differentiation pathway into GC B cells. Although it is still argued 445 Fukuda et al. that these cells originate from distinct cell lineages (41, 42) , Bcl6 is a regulator for the differentiation of GC B cells. Bcl6 expression is upregulated in nascent GC B cells (data not shown) and detected in both centroblasts and centrocytes in GCs from normal mice (Fig. 1) . Furthermore, GC formation is impaired in Bcl6-/-RM (Fig. 4) . Therefore, signals that upregulate Bcl6 expression in antigen-reactive B cells are essential for the differentiation of GC B cells. Stimulation of mature B cells with CD40L plus anti-IgM Ab induces phenotypic markers on GC B cells (43) , and LPS plus IL-4 induces RAG1 and RAG2 expression (44) and Ig isotype class-switching in B cells like GC B cells (45) . However, these signals cannot make upregulation of Bcl6 expression in mature B cells (data not shown; reference 46). Interactions of antigen-reactive B cells with helper T cells in PALS through cell surface molecules such as CD40-CD40L and CD86(B7-2)-CD28 are required for the differentiation (47) (48) (49) (50) (51) . Because the blocking of these interactions inhibits both primary Abs production and GC formation, signals from these interactions may be required for both differentiation pathways. Follicular dendritic cells are unique cells in follicles (19) . Helper T cells in GCs have also unique characters that are distinct from those of helper T cells in PALS (52, 53) . These cells seem to be required for GC formation by antigen-reactive B cells. Interactions of the B cells with these dendritic cells or GC-helper T cells may be a possible origin of the signals that upregulate Bcl6. Further study on the signals will be able to elucidate the molecular mechanism of differentiation into GC B cells.
GC formation is also impaired in mice lacking genes other than Bcl6. Lymphotoxin-c~-(54) or TNF-ot-deficient mice (55) can produce primary IgG1 Abs without GC formation like Bcl6-/-RM. The defect in GC formation may be due to the abnormality ofmicroarchitecture of spleens (56) . Chemokine receptor, Blrl-deficient mice also produce normal levels of primary IgGl Abs without functional GCs (57) . Although PNA-binding B cells are detected in PALS from the Blrl-deficient mice after immunization, these B cells fail to migrate from PALS into B cell follicles in the spleen. However, mature B cells from Bcl6-/-RM can migrate into follicles to form the normal microarchitecture of spleens (Fig. 4 F) . Mice lacking CD40 (47, 48) , complement receptors (C1L1 and CR2) (58, 59) , or CD28 (51) display impairments of both GC formation and primary IgG1 production to T cell-depedent antigens, but BcI6-/-RM produced normal levels of the primary IgG1 Abs (Fig. 3) . Therefore, the mechanism of the defect in GC formation in Bcl6-/-RM is distinct from the mechanisms in these deficient mice.
There are two distinct types of B cells in GCs: centroblasts and centrocytes. Several unique molecular events such as somatic hypermutation of the Ig gene, Ig isotype class-switching, selective cell death, and differentiation into memory B cells occur separately in each type of GC B cells (60) . Bcl6 expression is continuously upregulated in both types ofGC B cells (Fig. 1) , suggesting that Bcl6 is required not for each specific molecular event in GC B cells but for more fundamental events throughout GC reactions. These events may not be related with proliferation of GC B cells because Bcl6 is strongly detected in both cell cycling centroblasts and resting centrocytes (Fig. 1) and splenic B cells lacking Bcl6 can proliferate to various stimuli (Fig. 8) .
BCL6 was identified as an oncogene involved in chromosomal rearrangements in B cell lymphoma. Bcl6 expression is ubiquitous in mature tissues and is upregulated in cardiac myocytes, keratinocytes, and sperm at their terminal stages. Furthermore, Bcl6-deficient mice die'with spontaneous death of mature cardiac myocytes, suggesting that mature heart muscle without Bcl6 cannot maintain its differentiation stage. Although the GC stage is not a terminal stage of B cell differentiation, Bcl6 is continuously upregulated in GC B cells (Fig. 1) . If the specific function of Bcl6 is shared between B cells at the GC stage and heart muscle at the terminal stage, Bcl6 may be essential for protection of the GC B cells against specific stresses such as somatic hypermutation and selective cell death. Furthermore, this protective function may also contribute to lymphomagenesis ofGC B cells by deregulation of BCL6.
